Trials / Terminated
TerminatedNCT01737957
Safety and Efficacy of Low-Fluence PRP for PDR
Safety and Efficacy of Single-session, Low-fluence Panretinal Photocoagulation (PRP) for Proliferative Diabetic Retinopathy (PDR)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Asociación para Evitar la Ceguera en México · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and efficacy of a single session of low-fluence panretinal photocoagulation when compared to full-fluence PRP. Hypothesis: a single-session of low-fluence PRP will be safe regarding the progression of macular edema and the presence of adverse events, and will efficiently induce regression of neovascularization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low-fluence PRP with 532nm green LASER | To administer low-fluence PRP in a single session for PDR |
| DEVICE | Full-Fluence PRP with 532nm LASER | To administer full-fluence PRP in two sessions for PDR |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-11-30
- Last updated
- 2024-05-30
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01737957. Inclusion in this directory is not an endorsement.